Best Grants for 501(c)(3) in Northern Mariana Islands

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Chronic Lymphocytic Leukemia (CLL) Fund

Help with healthcare costs for chronic lymphocytic leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See Approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Canine Cancer Immunotherapy Network (K9CIN) aims to advance canine cancer treatments through innovative clinical trials, paralleling the development of human therapies. This initiative is vital as pet dogs naturally develop cancer, mirroring human responses to treatments. By leveraging NIH support, K9CIN will facilitate research to enhance immunotherapeutic strategies for both dogs and humans, fostering a collaborative environment for veterinary and human medical advancements. Ultimately, this funding opportunity promotes ethical research that benefits both species.

The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) aims to develop a new generation of independent investigators in patient-oriented research focused on pain management. This K23 award provides essential funding to support early-career researchers, enabling them to establish independent research programs aligned with the NIH HEAL Initiative. Key application deadlines span from October 2024 to June 2027, ensuring opportunities for renewals and resubmissions. This program is vital for advancing pain management research.

The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) offers Mentored Clinical Scientist Development Awards (K08) to support emerging independent researchers in pain management. This program aims to develop a new generation of skilled investigators by providing essential NIH research funding during their early careers. Notable deadlines for grant applications range from October 2024 to June 2027, ensuring ample opportunity for applicants to submit their proposals and enhance their research capabilities.

The NCI Pathway to Independence Award (K99/R00) aims to support talented postdoctoral researchers in their transition to independent faculty positions. This program provides essential NCI research funding to help awardees establish competitive, independent research careers. Applications must be submitted by 5:00 PM local time of the applicant's organization, ensuring timely consideration for this critical funding opportunity.

The ONR FY27 Young Investigator Program invites cutting-edge research proposals in priority areas that align with the interests of ONR Program Officers. This federal funding opportunity aims to support innovative projects led by early-career researchers, fostering advancements in science and technology relevant to the Navy. Interested applicants can find detailed eligibility criteria and contact information on the ONR website, encouraging collaboration and engagement in impactful research.

The NSF MPS Chemistry Research Programs support groundbreaking research in chemical sciences, encompassing areas such as chemical catalysis, measurement, imaging, and theory. This initiative encourages innovative proposals that can lead to transformative advancements, without the necessity of immediate commercial applications. Researchers interested in exploring foundational concepts that could shape the future of chemistry are invited to submit their ideas for funding.

The Interventions to Reduce Sleep Health Disparities (R01) grant aims to fund non-pharmacological strategies that enhance sleep health and address disparities in sleep among affected populations. The program emphasizes innovative approaches to examine sleep as a crucial element in mitigating health disparities across various health outcomes. Deadlines for applications range from February 2025 to June 2027, supporting both standard and renewal submissions under the National Institutes of Health.

The BRAIN Initiative aims to create web-accessible data archives to enhance research on brain science by offering tools for data analysis and visualization. This effort, led by the National Institute of Mental Health in collaboration with other NIH Institutes, seeks to establish a framework for rigorous data sharing and collaboration across various sub-domains. The initiative will enable the scientific community to access standardized and comprehensive data archives to support innovative neurotechnology research.

The Rural Health Network Development Program aims to enhance health care access in rural areas by supporting integrated health care networks. It offers two funding tracts: the Network Advancement Tract for established networks to overcome operational barriers and the Network Development Tract for early-stage networks to plan and expand services. Both tracts focus on improving care coordination, health outcomes, and operational efficiency, thereby strengthening the rural health care system.

The Pilot Projects to Enhance the Human Virome Program (R03) aims to support small-scale research projects that enhance the understanding of the human virome. This initiative encourages innovative approaches to study virome interactions and improve tools developed under the Human Virome Program. By leveraging human and animal specimens, projects should foster collaboration and expand existing research efforts, ultimately contributing to a deeper understanding of the virome's role in health and disease.

The Rural Health Network Development Planning Program aims to enhance rural health care by fostering integrated health care networks. It focuses on collaboration among entities to bolster local capacity and improve care coordination in underserved areas. By achieving efficiencies and expanding access to essential services, the program seeks to strengthen the overall rural health system while promoting the use of health information technology and exploring innovative care delivery models.

The Mentored Research Scientist Career Development Award (KR1) offers crucial support for researchers aiming for independence. Funded by the US Dept. of Health & Human Services through the NIH, this award allows candidates to engage in intensive research training under a mentor's guidance for up to five years. It is designed for those with research doctoral degrees, facilitating their transition into independent research roles and enhancing their contributions to the scientific community.

The FY 2027 State and Regional Primary Care Association (PCA) Cooperative Agreements aim to enhance the technical assistance provided to Health Center Program award recipients and look-alikes. This initiative focuses on improving access to preventive and primary health care, managing chronic diseases, and ensuring a capable health center workforce. By implementing value-based care strategies and leveraging data for operational improvements, the program seeks to support the health of vulnerable communities effectively.

The RNomics Technology Enhancement Centers, supported by the NIH Common Fund, aim to enhance tools for comprehensive RNA analysis, facilitating insights into health and disease. This initiative focuses on developing technologies for RNA sequencing, modification mapping, and functional testing. By fostering collaborations and strengthening existing resources, RTECs will advance the study of RNA molecules, ensuring broad community access to improved experimental and computational methods.

The RNomics Outreach and Coordination (ROC) Center, established by the NIH Common Fund, aims to enhance understanding of RNA molecules through integrated analysis. This center will serve as a hub for data management and community engagement, developing a central data portal, supporting data standards, and coordinating consortium-wide analyses. By fostering collaborations and providing training, the ROC Center seeks to ensure the long-term availability of essential RNomics resources, ultimately advancing health and disease research.

The Mentored Clinician Research Scientist Career Development Award (KC1) from the NIH supports clinician research scientists for up to five years, providing dedicated time for intensive research career development. This award aims to guide candidates with clinical doctoral degrees towards achieving research independence by pairing them with experienced mentors who can help navigate their career paths.

The BJA FY 2026 Capital Case Litigation Initiative aims to enhance legal representation in state capital cases. By providing essential funding, this initiative supports both prosecutors and defense attorneys to ensure equitable legal processes for indigent defendants. The U.S. Department of Justice emphasizes the importance of upholding the rule of law and protecting citizens' rights. Applications are due by November 5, 2026, at 8:59 p.m. ET, marking a critical opportunity for improvement in capital case litigation.

The CDC's NCIPC invites proposals for rigorous evaluations of programs aimed at preventing child sexual abuse (CSA) and problematic sexual behavior (PSB) among youth. This research aims to assess the effectiveness of prevention policies, especially in digital spaces and youth-serving organizations. Eligible proposals should address issues like online exploitation, harmful behaviors, and the impact of organizational policies on youth safety. This initiative seeks to enhance the evidence base for effective prevention strategies.

The E.B. Henderson Award, presented by SHAPE America, honors minority members who have demonstrated exceptional commitment to scholarship, mentorship, and advocacy for ethnic minorities within health and physical education. Established in 1885, SHAPE America serves over 200,000 professionals, promoting high-quality education standards. The award recognizes individuals who have significantly contributed to increasing the participation of underserved populations in the field. Limited to two awards annually, it highlights the importance of diversity and inclusion in health education.

The CDC's NCIPC invites research proposals to evaluate innovative approaches for preventing firearm-related violence and injuries. This initiative emphasizes the importance of data-driven solutions without infringing on legal firearm ownership rights. Funding options are available for existing data evaluations (up to $350,000/year for 2 years) or new data collection (up to $650,000/year for 3 years). Target areas include mass shootings, suicides, and crime prevention across various demographics and settings.

The BJA FY 2026 Adult Treatment Court Program aims to enhance Adult Treatment Court operations, focusing on preventing overdoses and reducing substance use among high-risk adults in the criminal justice system. The program integrates judicial supervision, substance use disorder treatment, and recovery support services to improve outcomes for participants. This funding opportunity from the U.S. Department of Justice highlights the commitment to public safety and addressing critical issues like the opioid crisis.

The BRAIN Initiative seeks innovative proposals for preclinical proof of concept studies on novel recording and modulation technologies aimed at diagnosing and treating central nervous system (CNS) disorders. This initiative supports diverse, multidisciplinary teams to enhance our understanding of the human CNS and prepare technologies for first-in-human studies. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 60 days prior to the proposal deadline.

This grant opportunity from the NIH aims to enhance mechanistic research on precision probiotic therapies through a biphasic R61/R33 award mechanism. It encourages innovative studies to identify specific biological factors influencing probiotic responses, thereby improving clinical outcomes. The program supports up to five years of research, with the initial phase focused on discovering unique host characteristics and the second phase assessing improvements in probiotic efficacy through rigorous studies.

The National Human Genome Research Institute (NHGRI) is launching a funding opportunity for the ancient DNA for Modern Genomics (aDMG) program. This initiative aims to create an ethical resource of ancient human DNA to enhance understanding of modern human traits and health. By leveraging both existing and new aDNA data, the program seeks innovative collaborations that integrate ancient and contemporary genomic information. Researchers with expertise in population genomics are encouraged to apply.

The Blueprint Neurotherapeutics Network (BPN) at the NIH aims to advance small molecule drug discovery and development. This program supports investigators in their own labs while offering access to NIH experts and contract research organizations. By combining NIH resources with industry expertise, BPN reduces risks in drug development, enabling partners to undertake late-stage projects. Focused on small molecules, it uses a cooperative agreement mechanism to support innovative, higher-risk projects, fostering essential collaborations for successful therapeutic advancements.